查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813813

全球皮膚科 CRO 市場：市場規模、佔有率、趨勢分析（按類型、服務和地區）、細分市場預測（2025-2033）

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Preclinical, Clinical), By Service (Clinical Monitoring, Project Management/Clinical Supply Management, Data Management), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

皮膚科CRO市場概述

預計 2024 年全球皮膚病學 CRO 市場價值將達到 54.2 億美元，到 2033 年將達到 90.9 億美元，2025 年至 2033 年的複合年成長率為 5.80%。

皮膚病學委外研發機構(CRO) 市場正在經歷強勁成長，主要原因是全球牛皮癬、濕疹、痤瘡和皮膚癌等慢性皮膚病的盛行率不斷上升。

此外，皮膚病學相關企業日益成長的興趣、人們對皮膚病健康的認知不斷提高以及創新局部和全身治療的生物製藥管道的不斷擴大，進一步推動了對專業臨床研究服務的需求。此外，皮膚病學研發投資的增加、個人化醫療的日益普及以及數位工具促進的患者參與度的提高等因素預計將支持市場成長。

此外，分散式臨床試驗、遠距皮膚病學和人工智慧皮膚成像等新興趨勢正在重塑皮膚病學臨床試驗的格局，改善患者可近性和數據準確性。穿戴式皮膚感測器和先進成像技術的日益普及，進一步增強了即時監測和終點評估。整體而言，由於政府加強對皮膚病學研究的支持舉措，美容皮膚病學應用的拓展，以及亞太和拉丁美洲等新興地區臨床試驗活動的增多，市場前景看好。

此外，CRO 正在採取策略性舉措，例如擴大其地理覆蓋範圍、與技術提供者合作以及投資整合數位平台，以提供全面的皮膚病學臨床試驗解決方案。此外，用於病變分析的人工智慧和機器學習、分散式臨床試驗平台和真實世界數據整合等技術進步使 CRO 能夠提高臨床試驗效率、患者參與度和數據質量，從而增強其在這個充滿活力的市場中的競爭地位。

目錄

第1章 分析方法與範圍

第2章執行摘要

第 3 章：皮膚科 CRO 市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 定價模式分析
  • 技術狀況
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第 4 章：皮膚科 CRO 市場：按類型估算和趨勢分析

  • 皮膚科 CRO 市場：細分儀表板（按類型）
  • 皮膚科 CRO 市場：按類型進行趨勢分析
  • 按類型（2021-2033）
  • 藥物研發
    • 目標檢驗
    • 線索識別
    • 先導藥物最適化
  • 臨床前
  • 臨床
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段

第5章：皮膚科 CRO 市場：依服務估算與趨勢分析

  • 皮膚科 CRO 市場：細分儀表板（按服務分類）
  • 皮膚科CRO市場：依服務類別的波動分析
  • 依服務分類（2021-2033 年）
  • 計劃管理/臨床供應管理
  • 資料管理
  • 監管/醫療事務
  • 醫學寫作
  • 臨床監測
  • 品管/保證
  • 生物統計學
  • 研究人員付款
  • 實驗室
  • 招募病患和設施
  • 科技
  • 其他

第6章：皮膚科 CRO 市場：按地區分類的估計和趨勢分析

  • 市場儀表板：按地區
  • 各地區市佔率分析（2024 年及 2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 市場參與企業分類
    • 市場領導
    • 新興玩家
  • 公司市佔率/評級分析（2024年）
  • 公司簡介
    • IQVIA Inc.
    • Labcorp Drug Development
    • Thermo Fisher Scientific Inc.（PPD）
    • Parexel International Corp.
    • Charles River Laboratories
    • ICON, Plc
    • Syneos Health
    • Pharmaron
    • Aragen Life Sciences Ltd.
    • Wuxi AppTec
    • MEDPACE
    • CTI Clinical Trial &Consulting
    • Bioskin
    • Proinnovera GmbH
    • Biorasi, LLC
Product Code: GVR-4-68039-635-9

Dermatology CRO Market Summary

The global dermatology CRO market size was estimated at USD 5.42 billion in 2024 and is projected to reach USD 9.09 billion by 2033, growing at a CAGR of 5.80% from 2025 to 2033. The dermatology contract research organization (CRO) market is experiencing robust growth, primarily driven by the rising prevalence of chronic skin conditions such as psoriasis, eczema, acne, and skin cancers across the globe.

Besides, growing interest of dermatological companies and increasing awareness of dermatological health, coupled with the expansion of the biopharmaceutical pipeline for innovative topical and systemic therapies is further driving the demand for specialized clinical research services. In addition, factors such as growing investments in dermatology R&D, the rising adoption of personalized medicine, and enhanced patient participation facilitated by digital tools are expected to support the market growth.

Moreover, the emerging trends such as decentralized clinical trials, tele dermatology, and AI-powered skin imaging are reshaping the dermatology clinical trial landscape, improving patient access and data accuracy. The increased use of wearable skin sensors and advanced imaging technologies is further enhancing real-time monitoring and endpoint assessment. Overall, the market scenario is favorable due to rising government initiatives supporting dermatology research, expanding applications in cosmetic dermatology, and increased clinical trial activity in emerging regions like Asia-Pacific and Latin America.

Furthermore, the CROs are taking strategic initiatives such as expanding their geographic presence, forming partnerships with technology providers, and investing in integrated digital platforms to offer comprehensive dermatology trial solutions. In addition, technology advancements, including AI and machine learning for lesion analysis, decentralized trial platforms, and the integration of real-world data, enable CROs to enhance trial efficiency, patient engagement, and data quality, strengthening their competitive position in this dynamic market.

Global Dermatology CRO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dermatology CRO market report based on type, service, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead optimization
  • Preclinical
  • Clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and Site Recruitment
  • Technology
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Service
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Value-Chain-Based Sizing & Forecasting
    • 1.7.3. Multivariate Model Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Dermatology CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence of Chronic and Complex Skin Disorders
      • 3.2.1.2. Increasing Adoption of Advanced Technologies
      • 3.2.1.3. Growing Demand for Aesthetic Dermatology and Cosmeceuticals
      • 3.2.1.4. Increasing Outsourcing of R&D Activities
      • 3.2.1.5. Favorable Environment for Clinical Trials in Developing Countries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Quality Issues of CRO Services
      • 3.2.2.2. Intellectual Property Rights Issues
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Dermatology CRO Market: Type Estimates & Trend Analysis

  • 4.1. Dermatology CRO Market, By Type: Segment Dashboard
  • 4.2. Dermatology CRO Market, By Type: Movement Analysis
  • 4.3. Dermatology CRO Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
  • 4.4. Drug Discovery
    • 4.4.1. Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Target Validation
      • 4.4.2.1. Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Lead Identification
      • 4.4.3.1. Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Lead Optimization
      • 4.4.4.1. Lead Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Clinical
    • 4.6.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Phase I
      • 4.6.2.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Phase II
      • 4.6.3.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Phase III
      • 4.6.4.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Phase IV
      • 4.6.5.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Dermatology CRO Market: Service Estimates & Trend Analysis

  • 5.1. Dermatology CRO Market, By Service: Segment Dashboard
  • 5.2. Dermatology CRO Market, By Service: Movement Analysis
  • 5.3. Dermatology CRO Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. Project Management/Clinical Supply Management
    • 5.4.1. Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Data Management
    • 5.5.1. Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Regulatory/Medical Affairs
    • 5.6.1. Regulatory/Medical Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Medical Writing
    • 5.7.1. Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Clinical Monitoring
    • 5.8.1. Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Quality Management/ Assurance
    • 5.9.1. Quality Management/ Assurance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Bio-statistics
    • 5.10.1. Bio-statistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Investigator Payments
    • 5.11.1. Investigator Payments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Laboratory
    • 5.12.1. Laboratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.13. Patient and Site Recruitment
    • 5.13.1. Patient and Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.14. Technology
    • 5.14.1. Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.15. Others
    • 5.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Dermatology CRO Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2033
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Australia
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. IQVIA Inc.
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Labcorp Drug Development
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Thermo Fisher Scientific Inc. (PPD)
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Parexel International Corp.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Charles River Laboratories
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. ICON, Plc
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Syneos Health
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Pharmaron
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Aragen Life Sciences Ltd.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Wuxi AppTec
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. MEDPACE
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. CTI Clinical Trial & Consulting
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Bioskin
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Service Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Proinnovera GmbH
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Service Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. Biorasi, LLC
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Service Benchmarking
      • 7.3.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 4 Global Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 5 Global Dermatology CRO Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 6 North America Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 8 North America Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 9 U.S. Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 10 U.S. Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 Canada Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 12 Canada Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 13 Mexico Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 14 Mexico Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 15 Europe Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 16 Europe Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 17 Europe Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 UK Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 19 UK Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 20 Germany Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 21 Germany Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 France Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 23 France Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24 Italy Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 25 Italy Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 26 Spain Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 27 Spain Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Denmark Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 29 Denmark Dermatology CRO Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 30 Sweden Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 31 Sweden Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 32 Norway Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 33 Norway Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 Japan Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 38 Japan Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39 China Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 40 China Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 41 India Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 42 India Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Thailand Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 44 Thailand Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45 South Korea Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 46 South Korea Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 47 Australia Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 48 Australia Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 49 Latin America Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 51 Latin America Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 52 Brazil Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 53 Brazil Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 54 Argentina Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 55 Argentina Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 59 South Africa Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 60 South Africa Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 63 UAE Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 64 UAE Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value-chain Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-up Approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent Market Outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary Market Outlook, 2024 (USD Billion)
  • Fig. 16 Dermatology CRO Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Dermatology CRO Market: Type Outlook and Key Takeaways
  • Fig. 20 Dermatology CRO Market: Type Movement Analysis
  • Fig. 21 Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Lead optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Dermatology CRO Market: Service Outlook and Key Takeaways
  • Fig. 32 Dermatology CRO Market: Service Movement Analysis
  • Fig. 33 Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Regulatory/Medical Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Quality Management/ Assurance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Bio-statistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Investigator Payments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Laboratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Patient and Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Thailand Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 UAE Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Kuwait Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key Company Categorization
  • Fig. 98 Service Heat Map Analysis
  • Fig. 99 Strategic Framework